IFP Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | -$134 | – | 4250 |
|
|
2025
Q1 | – | Hold |
0
| – | -$111 | – | 3781 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3992 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3358 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 3069 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 3007 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2941 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2839 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2731 |
|
|
2020
Q1 | – | Sell |
-54
| Closed | -$3K | – | 2732 |
|
|
2019
Q4 | $3K | Buy |
54
+7
| +15% | +$389 | ﹤0.01% | 2329 |
|
|
2019
Q3 | $3K | Buy |
+47
| New | +$3K | ﹤0.01% | 2493 |
|
|
2019
Q1 | – | Sell |
-75
| Closed | -$3K | – | 2390 |
|
|
2018
Q4 | $3K | Sell |
75
-24
| -24% | -$960 | ﹤0.01% | 2961 |
|
|
2018
Q3 | $6K | Buy |
99
+17
| +21% | +$1.03K | ﹤0.01% | 3068 |
|
|
2018
Q2 | $5K | Sell |
82
-43
| -34% | -$2.62K | ﹤0.01% | 3179 |
|
|
2018
Q1 | $8K | Hold |
125
| – | – | ﹤0.01% | 2901 |
|
|
2017
Q4 | $8K | Sell |
125
-26
| -17% | -$1.66K | ﹤0.01% | 2898 |
|
|
2017
Q3 | $8K | Hold |
151
| – | – | ﹤0.01% | 3090 |
|
|
2017
Q2 | $7K | Buy |
151
+16
| +12% | +$742 | ﹤0.01% | 3176 |
|
|
2017
Q1 | $7K | Buy |
135
+18
| +15% | +$933 | ﹤0.01% | 3061 |
|
|
2016
Q4 | $7K | Hold |
117
| – | – | ﹤0.01% | 3070 |
|
|
2016
Q3 | $8K | Buy |
117
+100
| +588% | +$6.84K | ﹤0.01% | 2932 |
|
|
2016
Q2 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 3564 |
|
|
2016
Q1 | – | Sell |
-17
| Closed | -$1K | – | 2398 |
|
|
2015
Q4 | $1K | Buy |
+17
| New | +$1K | ﹤0.01% | 3458 |
|